Overview

Comparative Clinical Trial of Efficacy and Safety of BCD-055 and Remicade® in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis

Status:
Completed

Trial end date:
2018-07-01

Target enrollment:

Participant gender:

Summary

BCD-055-3 is international multi-center comparative double-blind randomized clinical trial of efficacy and safety of BCD-055 (JSC "BIOCAD", Russia) and Remicade® in combination with methotrexate in patients with active rheumatoid arthritis.

Phase:

Phase 3

Details

Lead Sponsor:

Biocad

Treatments:

Folic Acid
Infliximab
Methotrexate
Vitamin B Complex